Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

NCT01847170 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beth Israel Deaconess Medical Center

Collaborators